Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,511 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Peptide-based vaccination for colorectal cancer.
Tsuruma T, Hata F, Furuhata T, Ohmura T, Katsuramaki T, Yamaguchi K, Kimura Y, Torigoe T, Sato N, Hirata K. Tsuruma T, et al. Among authors: yamaguchi k. Expert Opin Biol Ther. 2005 Jun;5(6):799-807. doi: 10.1517/14712598.5.6.799. Expert Opin Biol Ther. 2005. PMID: 15952910 Review.
Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer.
Tsuruma T, Iwayama Y, Ohmura T, Katsuramaki T, Hata F, Furuhata T, Yamaguchi K, Kimura Y, Torigoe T, Toyota N, Yagihashi A, Hirohashi Y, Asanuma H, Shimozawa K, Okazaki M, Mizushima Y, Nomura N, Sato N, Hirata K. Tsuruma T, et al. Among authors: yamaguchi k. J Transl Med. 2008 May 10;6:24. doi: 10.1186/1479-5876-6-24. J Transl Med. 2008. PMID: 18471305 Free PMC article. Clinical Trial.
Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer.
Tsuruma T, Hata F, Torigoe T, Furuhata T, Idenoue S, Kurotaki T, Yamamoto M, Yagihashi A, Ohmura T, Yamaguchi K, Katsuramaki T, Yasoshima T, Sasaki K, Mizushima Y, Minamida H, Kimura H, Akiyama M, Hirohashi Y, Asanuma H, Tamura Y, Shimozawa K, Sato N, Hirata K. Tsuruma T, et al. Among authors: yamaguchi k. J Transl Med. 2004 Jun 13;2(1):19. doi: 10.1186/1479-5876-2-19. J Transl Med. 2004. PMID: 15193151 Free PMC article.
A potent immunogenic general cancer vaccine that targets survivin, an inhibitor of apoptosis proteins.
Idenoue S, Hirohashi Y, Torigoe T, Sato Y, Tamura Y, Hariu H, Yamamoto M, Kurotaki T, Tsuruma T, Asanuma H, Kanaseki T, Ikeda H, Kashiwagi K, Okazaki M, Sasaki K, Sato T, Ohmura T, Hata F, Yamaguchi K, Hirata K, Sato N. Idenoue S, et al. Among authors: yamaguchi k. Clin Cancer Res. 2005 Feb 15;11(4):1474-82. doi: 10.1158/1078-0432.CCR-03-0817. Clin Cancer Res. 2005. PMID: 15746049
[Pharmacokinetics of S-1].
Hirata K, Horikoshi N, Tominaga K, Sohma K, Yamaguchi K, Okazaki M, Furuhata T, Sasaki K, Nakano Y, Ishizuka H, Yamada Y, Uno S, Taguchi T, Yamamitsu S, Shirasaka T. Hirata K, et al. Among authors: yamaguchi k. Gan To Kagaku Ryoho. 2006 Jun;33 Suppl 1:27-35. Gan To Kagaku Ryoho. 2006. PMID: 16897969 Review. Japanese.
7,511 results